Clinical trial
Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for…
NCT00468351 · University of Sao Paulo, Other · Unknown status
Key facts
| NCT number | NCT00468351 |
|---|---|
| Title | Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study) |
| Official title | Intravitreal Bevacizumab Versus Intravitreal Triamcinolone Acetonide for Refractory Diabetic Macular Edema |
| Acronym | IBEME |
| Lead sponsor | University of Sao Paulo, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Procedure |
| Interventions | Intravitreal Injection of 1, 5 mg of bevacizumab, Intravitreal injection of 4 mg of Triamcinolone acetonide |
| Start date | Apr 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | May 2, 2007 |
| Last update posted | May 2, 2007 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: